Antares Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Antares Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 23% to $183,982,000. Profit margin reached 25%. Total operating expenses were $156,640,000.
Profit Margin
| 2012 | 22.57M | -11.42M | -50.62% |
|---|---|---|---|
| 2013 | 20.61M | -20.50M | -99.46% |
| 2014 | 26.50M | -35.15M | -132.64% |
| 2015 | 45.65M | -20.65M | -45.25% |
| 2016 | 52.22M | -24.33M | -46.61% |
| 2017 | 54.51M | -16.74M | -30.71% |
| 2018 | 63.55M | -6.51M | -10.25% |
| 2019 | 123.86M | -2.02M | -1.64% |
| 2020 | 149.59M | 56.20M | 37.57% |
| 2021 | 183.98M | 46.28M | 25.16% |
ATRS Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 183.98M | 149.59M | 123.86M | 63.55M | 54.51M | 52.22M | 45.65M | 26.50M | 20.61M | 22.57M |
Cost of revenue | 68.28M | 63.1M | 50.47M | 31.06M | 27.46M | 28.81M | 19.45M | 11.23M | 9.19M | 9.52M |
Gross profit | 115.70M | 86.49M | 73.38M | 32.48M | 27.04M | 23.40M | 26.20M | 15.26M | 11.42M | 13.05M |
Operating exp. | ||||||||||
Research and development | 14.50M | 10.12M | 10.62M | 12.32M | 13.14M | 21.12M | 19.73M | 18.63M | 15.26M | 14.92M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.71M | 2.38M |
Total operating expenses | 156.64M | 72.88M | 72.39M | 49.09M | 43.5M | 47.52M | 46.66M | 50.37M | 32.27M | 24.50M |
Operating income | 62.27M | 13.61M | 992K | -4.10M | -16.45M | -24.11M | -20.46M | -35.11M | -20.85M | -11.45M |
Other income (expenses), net | 0 | -3.69M | -3.01M | -2.41M | -292K | -122.34K | -21.86K | -13.42K | 43.54K | 24.04K |
Income before tax | 62.27M | 9.92M | -2.02M | -6.51M | -16.74M | -24.23M | -20.48M | -35.12M | -20.80M | -11.42M |
Income tax expense | 15.98M | -46.28M | 530K | 261K | 1.13M | 100K | 175K | 25K | -300K | 0 |
Net income | 46.28M | 56.20M | -2.02M | -6.51M | -16.74M | -24.33M | -20.65M | -35.15M | -20.50M | -11.42M |
Earnings per share | ||||||||||
Basic EPS | 0.27 | 0.33 | -0.01 | -0.04 | -0.11 | -0.16 | -0.14 | -0.27 | -0.16 | -0.1 |
Diluted EPS | 0.27 | 0.33 | -0.01 | -0.04 | -0.11 | -0.16 | -0.14 | -0.27 | -0.16 | -0.1 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |